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ABSTRACT
Identification of Transcription Regulators of the AlgZ/R Two-Components Regulatory System in
Pseudomonas aeruginosa
by
Kwasi Oduro Yeboah
Pseudomonas aeruginosa is an opportunistic pathogen that express a plethora of virulence
components controlled through two-component regulatory systems that allow for sensing and
responding to environmental stimuli. This study was aimed at identifying transcription regulators
of algZ that encodes the histidine sensor kinase (AlgZ) of the AlgZR two-component regulatory
system. To understand how the algZ gene is transcriptionally controlled, transposon mutagenesis
was used to create a mutant library with varying algZ expression based on their b-Galactosidase
activity. The gene PA3327 was identified as a potential regulator of algZ expression using
arbitrary PCR. This gene encodes a probable non-ribosomal peptide synthetase responsible for
the biosynthesis of secondary metabolites such as antibiotics. Further experiments are required to
understand how PA3327 transcriptionally regulates algZ expression and its physiological role in
the organism. Because the AlgZ/R system regulates virulence, it is possible to attenuate
virulence by targeting the expression of algZ gene.
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CHAPTER 1: INTRODUCTION
Pseudomonas aeruginosa
Pseudomonas aeruginosa is a Gram negative opportunistic bacteria and a common
nosocomial pathogen known to cause life threatening infections in immunocompromised people
(Gellatly & Hancock, 2013). Patients with cystic fibrosis, HIV and people recovering from burn
wounds are usually at risk of P. aeruginosa infection (Gonzalez et al., 2016; Meynard et al.,
1999; Yetkin et al., 2006). P. aeruginosa is metabolically versatile and ubiquitous in the
environment, surviving even in the harshest of environments. This characteristic makes it
possible for P. aeruginosa to inhabit any tissue in the human body. P. aeruginosa possesses a
wide array of virulence factors that enables it to colonize, survive and damage host tissue while
evading detection and elimination by host immune system and antibiotic treatment. It is capable
of establishing an acute infection (Pankhaniya et al., 2004) characterized by the presence of pili
which mediates adherence, and twitching motility (Bradley, 1980). Pseudomonas aeruginosa
exhibit two types of virulence factors. Factors involved in acute (early stage) infection are either
on the surface or secreted. The type 4 pili responsible for adherence to epithelium, the
exoenzyme S and other adhesins reinforce the adherence to the epithelium. Factors involved in in
chronic infection includes siderophores (pyoverdine and pyochelin), which allows bacteria
growth in the absence of ferrous ions (Konings et al., 2013; Takase et al., 2000). Strains isolated
from patients with cystic fibrosis produce alginate that protects the bacterium from host immune
system, dehydration and antibiotics. Alginate production improves adherence to solid surface
forming biofilm. Development of alternative therapies for treatment of P. aeruginosa infections
is important because of its intrinsic and growing resistance to current antibiotics. One important
such alternative therapy is to target regulators of virulence factors using anti-virulence drugs
10

(Heras et al., 2015). This option can be used to inhibit the expression and activity of virulence
factors, facilitating eradication of infections by the host immune response (Leid et al., 2005) and
antibiotics (Alkawash et al., 2006). Understanding virulence factor regulation in P. aeruginosa is
essential to enable us to target regulatory signal responsible for modulating the numerous
virulence factors associated with acute and chronic infecting strains.
Virulence Factors
Bacterial virulence factors are cell surface and secreted proteins or biological molecules
such as exotoxins, flagella, type IV pili (T4P) and alginate produced by pathogenic bacteria that
enable them to colonize a niche in the host, evade and suppress host immune response, damage
host tissue, and also obtain nutrients from host (Ben Haj Khalifa et al., 2011; Fleitas Martínez et
al., 2019). P. aeruginosa virulence factors enables it to initiate and sustain infections or diseases
in different hosts and host tissues. Acute infecting strains are motile and are characterized by the
possession of early state virulence factors for tissue invasion, tissue necrosis, and attachment to
epithelium (Moradali et al., 2017). Chronic infecting strains are sessile, form biofilm and
produce alginate (Laventie et al., 2019).
In chronic infecting strains isolated from the lungs of patients with cystic fibrosis, the
biosynthesis and secretion of alginate is upregulated (May et al., 1991). This is due to the
increase in transcription of enzymes involved in alginate biosynthesis, maturation and secretion.
Alginate production and biofilm formation in chronic infecting strains makes them resistant to
host immune response and antibiotic treatments (Franklin et al., 2011; May et al., 1991).

Acute infecting strains cause rapid cell death or tissue damage. This is due to the
presence of the T3SS used to inject effector proteins directly into eukaryotic cells and exotoxin
11

A responsible for tissue necrosis and four protease responsible for bleeding and tissue necrosis
(Ben Haj Khalifa et al., 2011).
P. aeruginosa is capable of swimming, swarming and twitching motility. Virulence
factors mediating these forms of translocation are the T4P and flagella (O’Toole & Kolter, 1998;
Persat et al., 2015). These factors enable the bacteria to colonize new niches, as in the case of
acute pneumonia when the bacteria moves deeper into lungs from the endotracheal tubes
(Hauser, 2009; Sadikot et al., 2005). It has been demonstrated that when this bacterium
encounters a solid surface, c-di-GMP levels increases and stimulates pili assembly (Laventie et
al., 2019).
Regulation of virulence is important in pathogenic bacteria for survival and continuous
presence of a disease condition in a host (Wout et al., 2015) . Depending on the environmental
cues, the expression of certain virulence factors are upregulated and others repressed. When P.
aeruginosa is grown on a solid surface, planktonic cells transition into sessile cells upregulating
the expression of genes involved in biofilm formation and alginate biosynthesis (Petrova &
Sauer, 2011). P. aeruginosa virulence factors are tightly regulated using two-component systems
(TCS). This allows the bacteria to sense and respond to environmental cues through signaling
pathways which terminates in either activation or repression of gene transcription (Stephenson &
Hoch, 2002). The quorum sensing system is another means by which P. aeruginosa regulate the
expression of virulence genes necessary to the survival and proliferation in host (Whiteley et al.,
1999).
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Two-Component Regulatory Systems (TCS)
Bacterial survival depends on the ability to detect changes in the environmental and
mount the appropriate response by upregulating the expression of genes necessary for survival
and proliferation in the host (Tiwari et al., 2017). This survival instinct is mediated by twocomponent systems consisting of a membrane bound sensor (histidine) kinase and a cytoplasmic
response regulator. PilS-PilR system is an example of a quorum sensing system that regulates
type IV pilus expression, biofilm formation, twitching and swarming motility (Ishimoto & Lory,
1992; Kilmury & Burrows, 2016). The sensor kinase picks up environmental cues,
autophosphorylates and then relays this information into the cell via phosphorylation of the
response regulator (Francis et al., 2018). The phosphorylated response regulator then mediates
gene expression through DNA binding. Response regulators have been shown to have
transcription regulatory effect in both phosphorylated and unphosphorylated states (Deretic et al.,
1992; Ma et al., 1998). This is evident in P. aeruginosa AlgZ/R TCS where phosphorylated
AlgR drives the expression of the fimU operon leading to type IV pili assembly and
unphosphorylated AlgR drives the biosynthesis of alginate through activation of algC and algD
expression (Mohr et al., 1992; Zielinski et al., 1992). An example of response regulator
phosphorylation in P. aeruginosa is when AlgR phosphorylation by AlgZ results in the
expression fimU operon encoding minor pilins and the PilY1 protein necessary for twitching
motility and biofilm formation (Whitchurch et al., 2002) (Luo et al., 2015). In summary,
pathogenic bacteria rely on the use of the two-component transcriptional regulatory system for
survival and proliferation in the host (Ben Haj Khalifa et al., 2011). The genome of P.
aeruginosa encodes one of the largest complements of TCS regulatory proteins found in bacteria
and are responsible for the different phenotypes in P. aeruginosa (Rodrigue et al., 2000).
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Figure 1. Schematic representation of a generic bacteria two-component system.
Phosphorylation of response regulator results in downstream expression of desired genes

AlgZ/R Two-Component System
In P. aeruginosa, the AlgZ/R two-component system is of great importance because it
coordinates multiple phenotypes (Okkotsu et al., 2014). In this system, AlgZ is the membrane
bound sensor kinase, and AlgR is the cytoplasmic response regulator that acts as a transcriptional
regulator via DNA binding(Stephenson & Hoch, 2002). During signal transduction,
phosphorylation activate transcriptional regulators (Lukat et al., 1992). This is not the case with
AlgR since both phosphorylation states are capable of activating gene transcription (Okkotsu et
al., 2014). In the phosphorylated state, AlgR regulates twitching motility by activating the
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transcription and expression of the fimU operon encoding minor pilins important in pilus
biogenesis (Whitchurch et al., 1996).
In summary, the AlgZ/R TCS is essential in regulating important virulence factors in P.
aeruginosa and elucidating the regulation of the different components of the system (AlgZ and
AlgR) could uncover potential anti-virulence therapies for effectively combating P. aeruginosa
infections.
Regulation of algZ/R Operon
The genes encoded in the algZ/R operon are co-transcribed occasionally. However , the
presence of different and independent promoters for algZ and algR indicates the presence of
independent transcription regulation mechanisms for these genes (Pritchett et al., 2015). Two
independent promoters for algR are found within the algZ coding region. Recent studies have
identified two transcription initiation start sites for algZ upstream of the algZ coding
region(Pritchett et al., 2015) .

Figure 2. Schematic representation of AlgZ/R operon and the algZ transcriptional fusion.
Arrows denote promoters for algZ, algR, and algZ-lacZ transcriptional fusion. The
transcriptional fusion encodes b-Galactosidase.
Although algZ and algR are sometimes co-transcribed, the promoters presented in Figure
2 indicate that regulation of algR expression can occur independently of algZ expression.
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Transcriptional regulation of algR has been well studied in previously and is known to be
modulated by sigma factor AlgU and RpoS (Pritchett et al., 2015). Transcription of algZ on the
other hand is known to be regulated by virulence factor regulator (Vfr), which binds upstream of
algZ to intiate transcription. Previous studies have shown that the type IV minor pilins and PilY1
regulate virulence by modulating the activity of AlgZ/R two-component system in P. aeruginosa
(Marko et al., 2018). However, the exact mechanism of this regulation is still being investigated.
Our study aims to determine the regulators of algZ expression and their physiological roles in the
pathogenesis of P.aeruginosa. Since the PilY1 protein encoded in the fimU operon negatively
regulate algZ expression and this regulatory effect is not due to activity through cAMP-Vfr
signaling pathway, this unlocked the possibility for the potential discovery of novel regulators of
algZ expression. Promoter region upstream of algZ has an increased activity in a pilY1 mutant
but has no know regulators (Pritchett et al., 2015). This mutant background serve as reference
strain for identifying positive regulators of the promoter upstream of algZ since these positive
regulators repress or inhibit the promoter activity
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CHAPTER 2: MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Pseudomonas aeruginosa PAO1 wild-type strain was used as the reference strain in all
experimental procedures. All strains of P. aeruginosa (wild-type and mutants) used in all
experiments were grown at 37oC on Pseudomonas Isolation Agar (PIA) and PIA supplemented
with the appropriate antibiotics when necessary. For conjugation, P. aeruginosa was incubated at
42°C for 2 hours to inactivate the restriction modification system to allow for successful
integration of foreign DNA into its genome. The E. coli sm10 lpir strain containing the pBT20
plasmid was used for conjugation with DpilY1algZTF-lacZ to generate transposon mutants. E.
coli strain containing the pBT20 plasmid were grown at 37°C on LB plate supplemented with
gentamicin when appropriate. Conjugation reactions were performed on LB plate and incubated
at 30°C. For certain experimental procedures, P. aeruginosa strains were grown in LB broth
supplemented with antibiotics at 37°C with shaking between 8 to 16 hours. Freezer stocks of all
bacteria strains were made by mixing 360uL of 50% glycerol, 240uL of LB broth and 400uL of
bacterial culture in a freezer tube for storage at -80oC. Plasmids used in this study are listed in
Appendix C. Growth media and antibiotic concentrations are listed in Appendix A.
Transposon Mutagenesis
The pilY1 P. aeruginosa mutant containing the algZ transcriptional fusion
(DpilY1algZTF-lacZ) was grown on a PIA plate at 42OC overnight. The sm10 lpir E. coli strain
containing the mariner transposon on pBT20 plasmid was grown on LB agar supplemented with
15ug/uL gentamicin and incubated at 37oC overnight. Both strains of bacteria were scraped from
their plates, and resuspended in 500uL of sterile 0.85% saline in a 1.5mL microfuge tube and
plated on LB agar for 2hrs at 30oC to allow for conjugation. After 2hrs conjugants were scraped,
17

resuspended in 500uL of sterile 0.85% saline and plated PIA plate supplemented with 150ug/uL
gentamicin. Irgasan in PIA kills any remaining E. coli whiles gentamicin kills any P. aeruginosa
strain that does not take up the pBT20 plasmid during the conjugation. These plates were
incubated at 37°C for 16 – 24 hours. Isolated colonies representing mutants were then used for
High Throughput b-Galactosidase assay to identify mutants with significantly different reporter
activity.
High Throughput b-Galactosidase Assay
Isolated mutant colonies on PIA gentamicin plates were inoculated into 200uL LB broth
in a 96-well plate with the reference strain DpilY1algZTF-lacZ inoculated in well A1. The 96well plates were incubated for 8hrs at 37oC with shaking. Cells incubated more than 8hrs showed
clumping and biofilm formation leading to inaccurate results from the b-Galactosidase assay.
After the 8hrs incubation, optical density (OD) of each well was measured at 600nm using a
microtiter plate reader. To rule out the effect of a growth defect on our assay, mutant cells with
OD600 readings significantly reduced from neighboring cells were excluded from the screening.
Using a new 96-well, 100uL of permeabilization buffer was added to each well. From the initial
96-well plate, 10-30uL of 8hrs cultures was transferred into the 100uL permeabilization buffer
and mixed thoroughly by pipetting up and down several times. The plates were left for 10
minutes to settle. To each well 30uL of ONPG solution was added and reaction stopped with
70uL of 1M Na2CO3 solution when a yellow color developed. The reaction time from addition of
ONPG to cessation of reaction with Na2CO3 was noted and recorded for the first horizontal line
of wells (A1 to A12). The process was repeated for the remaining wells using the same reaction
time. The plates were centrifuged at 8000G and optical density of each well measured at 420nm
using the microtiter plate. Miller units were calculated using the formula below:
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1000* (OD420)/(OD600*volume of lysate*time)
Note, time is in minutes, and lysate volume is milliliters.
Confirmation of b-Galactosidase Assay
Using 1:100 dilution factor, 50uL of significant mutants from the High Throughput bGalactosidase assay were inoculated into 5mL LB broth supplemented with 150ug/ul gentamicin
and grown at 37oC with shaking for 8hrs. For confirmation assay, 750ul of cultures were spun at
8000G for 5 minutes. Supernatant discarded and pellet resuspended in 1mL chilled Z-buffer plus
2.7% b-mercaptoethanol (BME). Optical density was measured at 600nm and recorded. Then
50ul chloroform and 50ul 10% SDS were added to each reaction tube and vortexed to
permeabilize the cells. Mixture was allowed to sit for 10 minutes to settle and allow for
maximum permeabilization. Then 10-200uL of cell lysate was added to Z-buffer plus BME
solution and 200uL of ONPG added to make a volume of 1mL. Each reaction was stopped with
500uL of 1M Na2CO3 when a yellow color developed. Optical density of each reaction tube was
measured and recorded at 420nm and 550nm. Miller units were calculated using the following
equation:
1000* (OD420-(OD550*1.75)/(OD600*volume of lysate*time)
Note, time is in minutes, and lysate volume is milliliters.

Colony PCR
To screen for the presence of gentamicin gene in the transposon, colony PCR was
performed to confirm insertion of the gent gene into the genome of P. aeruginosa. Colony PCR
master mix was assembled on ice and 24uL aliquoted into PCR tubes. A single colony of mutant
of interest was transferred from a plate using a sterile tooth pick into the PCR tubes.
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Table 1. Colony PCR for Gentamicin Gene
Master Mix

PCR Program

Per sample:
95°C – 3 minutes

19uL ddH2O
2.5uL 10X PCR Buffer

95°C – 30 seconds

1uL DMSO

60°C – 30 seconds

0.5uL 10mM dNTPs
72°C – 2 minutes

0.5uL 10uL GentF primer
0.5uL 10uL GentR primer

Repeat steps 2-4 30 times

0.1uL Taq DNA polymerase

72°C – 5 minutes
4°C – Hold

20

Arbitrary PCR

(Kulasekara et al., 2005)

Figure 3. Shows the schematic representation of pBT20, the mariner transposon
mutagenesis vector. IRL and IRR: inverted repeats for trans position; GentR: aaC1 gene
encoding gentamicin resistance for positive selection of transposon insertions; AmpR: bla
gene encoding ampicillin resistance for plasmid conjugation; Ptac: the outward directed
tac promoter; Mariner C9 Transposases: encodes transposases for recombination; ter:
transcription termination; Ori R6Kg origin of replication; OriT: origin of transfer from
broad host range plasmid.

Genes interrupted by transposon were identified using arbitrary PCR. Arbitrary PCR is a
two-step PCR process which involves the arbitrary primers, two different PCR processes. A
single colony from a plate of a mutant of interest was inoculated into 3mL LB broth
supplemented with 150ug/ul gentamicin and incubated at 37oC for 16hrs with shaking. For DNA
template, 750ul of 16hrs culture was spun at 8000G for 5 minutes. Supernatant was discarded
and pellet resuspended in 1mL of arbitrary PCR lysis buffer. This solution was then heated at
21

95oC for 10 minutes and centrifuged at 8000G for 10 minutes. The resulting supernatant was
then used as template DNA in the arbitrary PCR reaction. While the cell lysing process was
occurring, the master mix for arbitrary PCR was assembled on ice. All primers used in the
arbitrary PCR are shown in Appendix C

(Das et al., 2005)
Figure 4. Principle of Arbitrary PCR. Arbitrary primers depicted as solid and striped red bind
randomly in the genome. The transposon specific primers depicted blue bind to the transposon and
create amplicons in conjunction with the arbitrary primers. Products from round one PCR are used
as templates for round two PCR. In the round two PCR, sequence specific primer (turquoise) paired
with the Arb2 primer identical to the 5’ sequence of the round one arbitrary primers. Round two
amplicons are subjected to gel electrophoresis and DNA sequencing.
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Table 2. Arbitrary PCR #1
Master Mix (ARB1)

ARB1 PCR Program

Per reaction:

1. 94oC – 3 minutes

36.25uL ddH2O

2. 94oC – 3 minutes

1uL DMSO

3. 49oC – 30 seconds (reduce temp
by 1oC for each subsequent round)

1uL 10nMdNTPs

4. 72oC – 3 minutes

5uL Thermopol buffer

5. Repeat steps 2-4 15 times

2uL 10uM ARB1 primer (RdPa1, RdPa2,
RdPa3, or combination of these primers)

6. 94oC – 30 seconds

2uL 10uM internal specific primer (R1TnM)

7. 60oC – 30 seconds

0.25uL Taq DNA polymerase

8. 72oC – 3minutes
9. Repeat steps 6-8 20 times
10. 12oC – Hold

To each PCR reaction tube, 46uL of the master mix was added along with 1.5uL of
supernatant from lysed cultures. Samples were transferred to a thermal cycler and run using the
ARB1 PCR program. At the end of the ARB1 program, master mix for ARB2 PCR was
assembled on ice.
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Table 3. Arbitrary PCR #2
Master mix (ARB2)

ARB2 PCR Program

Per reaction:

1. 94oC – 3 minutes

28.25 ddH2O

2. 94oC – 30 seconds

1uL DMSO

3. 60oC – 30 seconds

5uL Thermopol buffer

4. 72oC – 2 minutes

5uL 10uM ARB2 primer (Rd2Pa)

5. Repeat steps 2-4 30 times

5uL 10uM external specific primer

6. 72oC – 5 minutes

(R2TnM)

7. 12oC – Hold

0.25uL Taq DNA polymerase

For ARB2 PCR reactions, 43uL of master mix was aliquoted into PCR reaction tubes and
1.5uL of ARB1 PCR product added as template. The tubes were transferred to the thermal cycler
and ARB2 PCR program run.
At the end of the ARB2 PCR program, products were analyzed using agarose gel
electrophoresis to determine the band sizes of amplicons (appendix C). PCR products fromARB2
were cleaned up using the Monarch DNA Gel Extraction Kit (New England BioLabsÒ)
according to manufacturer’s instructions and sent to the ETSU Molecular Biology Core Facility
for sequencing.
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Growth Curves
To rule out the effect of a growth defect contributing to differences in algZ gene
expression, growth curve experiments were performed. Mutants and wild-type PAO1 P.
aeruginosa cells were inoculated into tubes containing 5mL LB broth. Tubes were incubated
overnight at 37OC with shaking. Cells were sub-cultured by taking 1% volume of parent culture
and diluting it in a flask containing 250mL LB broth and incubated at 37OC with shaking. At 4,
6, 8, 10, 12, and 24 hours, 1mL aliquots of cultures were removed and used for OD600
measurements.
Density at 600nm were measured and recorded at 6 time points. Results were graphed and
analyzed analyzed to determine growth defects between mutants and wild-type Pseudomonas
aeruginosa.
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CHAPTER 3: RESULTS
Beta-Galactosidase Assay
PilY1 Represses algZ Expression in Pseudomonas aeruginosa
Aside from playing an important role in mechanosensing, minor pilins and PilY1 protein
are involve in the regulation of AlgZ (Marko et al., 2018). For this reason, a pilY1 mutant was
constructed and used as a reference strain in a beta-galactosidase screening. Expression of algZ
was measured in the reference strain and transposon mutant strains using the algZ-lacZ
transcriptional fusion in a beta-galactosidase assay.

β-Galactosidase activity

algZ-lacZ
4000
3000
2000
1000
0
PAO1

ΔpilY1

Figure 5. algZ expression increases in DpilY1 relative to PAO1. b-Galactosidase activity
in these strains were measured in triplicates after growth of strains in LB broth for 8
hours. Statistical analysis (ttest) of expression in PAO1 and DpilY1 has a p<0.001
In the pilY1 mutant background, a significant increase in algZ expression was observed,
indicating that PilY1 represses algZ expression. Previous studies have shown that other minor
26

pilins such as pilW, pilV represses algZ expression (Marko et al., 2018). Effect of pilY1 on algR
expression was not assessed in this experiment.
Transposon Mutants Screen
To determine genes responsible for the increase in algZ expression in the pilY1 mutant
strain, a transposon mutagenesis screening was performed. E. coli strain sm10 lpir containing
pBT20 plasmid (Kulasekara et al., 2005) was conjugated with the Pseudomonas aeruginosa

DpilY1algZTF-lacZ strain. During the conjugation, the mariner transposon contained in the
pBT20 plasmid (Appendix C) inserts randomly in the chromosome of the P. aeruginosa,
inactivating genes resulting in changes in algZ expression in the transcriptional fusion.
Pseudomonas cells not transformed during conjugation die from the bactericidal effect of
gentamicin in the growth plate.
Approximately 5000 transposon mutants were screened during this experiment, out of this
number, 5 mutants were found to have significant decrease in algZ expression relative to the

DpilY1algZTF-lacZ strain.
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β-Galactosidase activity

algZ-lacZ

Figure 6. algZ expression in transposon mutants. Mutants generated had decreased algZ
expression relative to pilY1 mutant strain. TnM4 and TnM4 are hits corresponding to the
lacZ gene. TnM2 correspond to algR and TnM1 corresponds to PA3327 in P. aeruginosa
genome.

Comparing the b-Galactosidase activity of TnM1 and TnM2 (PA3327 & algR) to the
wild type PAO1 strain and the DpilY1 strain, TnM1 and TnM2 have significant reduced algZ
expression relative to the DpilY1 and similar algZ expression relative to the wild type PAO1
strain. Under the pilY1 mutant background, PA3327 acts as a potential positive regulator of algZ
expression.
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The lacZ gene encoding the beta-galactosidase enzyme was interrupted twice, these mutants
(TnM4 & TnM5) had no algZ expression because the insertion of the mariner transposon into the
lacZ gene inhibited the expression of the enzyme resulting in no measurement in the beta-gal
assay.
Gentamicin Resistance Screen
To select for transformed P. aeruginosa strains after conjugation with pBT20, the cells
were cultured on PIA gent plates (Appendix A). In some instances, Pseudomonas strains were
able to grow on PIA gent plate due to random insertions of gentamicin gene into their genome.
For this reason, colony PCR was used to screen for the presence of gentamicin gene in the
Pseudomonas mutants capable of growing on the PIA gent plates. The primers used for the
colony PCR were gentF and gentR (Appendix C). The E. coli sm10l-pBT20 was used as a
positive control for the colony PCR. Mutants with PCR products equal to the positive control
were used for downstream applications. All transposon mutants were screened for the insertion
of the mariner transposon in their chromosome prior to b-Galactosidase assay.
Arbitrary PCR
Genes interrupted by the transposon were identified using arbitrary PCR. For round one
arbitrary PCR in this experiment, RdPa1, RdPa2, and R1TnM (Appendix C) were used. Products
from the round one reaction were used for the round two reaction. In the round two reaction, the
primers Rd2Pa and the transposon specific primer R2TnM (Appendix C) were used. PCR
products were cleaned up using the Monarch DNA Gel Extraction Kit (New England BioLabsÒ)
as per instructions provided with the kit. Concentration and purity of round two PCR products
were determined using nanodrop.
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Figure 8. Gel electrophoresis of successful arbitrary PCR products. Round two PCR
results on an agarose gel. TnM1 shows two bands with sizes of approximately 500bp and
700bp. TnM2 shows a single band with a size of approximately 500bp. Samples were
screened and sequenced to identify the genes involved.
Growth Curves
Mutants were subjected to growth curve assay to determine if the genes interrupted
encoded proteins necessary for growth or biochemical processes involved in growth and
development.

Figure 11. Growth curve assay. Transposon mutant had a similar growth rate compared
to the wild type PAO1 and DpilY1 strains after 24 hours of growth at 37°C.
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The mutants with lacZ interrupted had no algZ expression when they were subjected to betaGalactosidase assay. All other mutants had relative reduced algZ expression compared with the
screening reference strain. A mucD mutant was identified in the screens. This mutant was
mucoid and protease deficient but had a relatively increased algZ expression compared with the
reference so was not added to our significant mutants.
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CHAPTER 4: DISCUSSION
The opportunist pathogen Pseudomonas aeruginosa is highly adaptable to different
environmental conditions due to the presence of a plethora of virulence factors at its disposal.
These virulence factors make Pseudomonas aeruginosa resistant to immune clearance and
antibiotic treatment, particularly in immunocompromised patients such as those undergoing
cancer treatment or those with cystic fibrosis or severe burn wounds. These virulence factors are
subject to complex regulation through two-component regulatory systems allowing sensing and
responding to environmental cues. Therefore understanding regulation of virulence factors in
Pseudomonas aeruginosa has become imperative for determining potential targets and
development of new anti-virulence therapies. Pseudomonas aeruginosa uses the AlgZ/R TCS to
regulate virulence gene expression in response to external stimuli. AlgR, the response regulator
encoded by the algR gene has been studied extensively with known regulators such as the Vfr,
Rpos, or AlgU but the signals sensed by AlgZ, the sensor kinase, remain unknown and regulation
of algZ expression has not been extensively studied though Vfr is known to regulate algZ
expression (Pritchett et al., 2015). The aim of this study was to identify novel regulators of algZ
expression and how they contribute to virulence. The potential for elucidating the regulation of
algZ expression includes attenuation of virulence through inhibition of algZ expression and also
contribute to the understanding of AlgZ signaling.
Regulators of algZ Identified via Transposon Mutagenesis
The use of transposon mutagenesis screens remain a powerful tool for the identification
of novel genes involved in controlling essential biological processes in bacteria. In Pseudomonas
aeruginosa, transposon mutagenesis has been used in the identification of virulence genes
encoding proteins necessary for disease causation and survival. The significance of transposon
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mutagenesis technique was shown in our screen for regulators of algZ expression (Kulasekara et
al., 2005). In the work, approximately 5000 mutants were screened and ten genes were identified
to as potential regulators of algZ expression. The genes identified include fimS, algR, lacZ and
PA3327. Of all the genes identified through transposon mutagenesis, the most interesting ones
were algR and PA3327.
Non-Ribosomal Peptide Synthetase (PA3327)
Pseudomonas aeruginosa genome encodes four uncharacterized Non-ribosomal Peptide
Synthetases (NRPSs) which play significant roles including the biosynthesis of secondary
metabolites (non-ribosomal peptides) such as siderophores, antibiotics, pigments and harmful
toxins (Martínez-Núñez & López, 2016). These non-ribosomal peptides play important roles in
cellular signaling, intra- and interspecies communication, and virulence. In the transposon
mutagenesis screening, PA3327 was identified and encodes a putative non-ribosomal peptide
synthetase and is part of an eight member gene cluster that includes a gene encoding an FADdependent monooxygenase. In a pilY1 mutant background and using beta-galactosidase assay,
inactivation of the NRPS encoded by PA3327 repressed the expression of algZ. To rule out polar
effects of PA3327 inactivation of downstream genes in the cluster, deletion mutants of all the
genes in the cluster should be made and their corresponding effects of algZ expression
determined using b-galactosidase activity. Although the PA3327 mutant did not exhibit any
phenotypic characteristic, it is expected to regulate the expression of some virulence factors due
to its regulatory effects on algZ expression leading to AlgR phosphorylation and subsequent
expression and repression of known virulence factors in P. aeruginosa.
Previous studies have shown that algZ expression is activated by the virulence factor
regulator (Vfr) which binds to sequences upstream of the transcriptional start site (Kanack et al.,
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2006). In another study it was shown that Vfr activates lasR (transcription regulator) expression
and a blast analysis revealed a LasR binding site upstream PA3327 transcriptional start site.
LasR acts as a transcriptional regulator of PA3327, indicating an indirect regulatory mechanism
between Vfr and PA3327 expression via LasR. The non-ribosomal peptide synthesized by the
NRPS PA3327 can be considered as a transcription enhancer, upregulating the expression of
algZ gene. To elucidate the signaling pathway and understand the role of PA3327 in algZ
expression and virulence regulation, PA3327 deletion construct expressing algZ_lacZ or
algZ_lux reporter in different mutant backgrounds of the genes known to regulate PA3327
expression should be made and algZ expression measured using beta-galactosidase assay. Since
AlgZR system regulates biofilm formation, twitching motility, cyanide production, and
rhamnolipids production, a PA3327 mutant would be tested to determine which of these
phenotypes it regulates by repressing the expression of algZ.
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Proposed Model of algZ Activation

Importance
In bacteria pathogenesis, virulence genes regulation is essential for disease causation and
survival of pathogens against host immune response and antibiotic treatment. Considering P.
aeruginosa pathogenesis, the AlgZ/R TCS regulate a number virulence factors and inactivation
of this system leading to virulence attenuation could be explored as possible therapeutic targets
to treat and prevent spread of P. aeruginosa infection. This opportunistic pathogen exhibits acute
phase virulence factors such as protease and exotoxins production, and chronic phase virulence
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factors such as biofilm formation and alginate production. Therefore exploring how PA3327
regulates algZ expression and virulence could be a great step towards the development of antivirulence drugs for treating Pseudomonas aeruginosa infections
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APPENDICES
Appendix A: Growth Media
Pseudomonas Isolation Agar (PIA) (1 Liter)
950mL ddH2O
20mL glycerol
25mg Irgasan
Bring to a boil, then add
20g peptone
10g potassium sulfate
1.4g magnesium chloride
15g agar
QS to 1000mL with ddH2O
Autoclave
Antibiotics:
150ug/uL gentamicin
Luria-Bertani (LB) (1 liter)
950mL ddH2O
10g tryptone
5g yeast extract
10g sodium chloride
10g-15g agar (depending on desired percentage)
QS to 1000mL with ddH2O
Autoclave
Antibiotics:
15ug/mL gentamicin
100ug/mL ampicillin
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Appendix B: Buffers
10X TAE Buffer (1Liter)
800mL ddH2O
48.5g Tris
11.4mL glacial acetic acid
20mL 0.5M EDTA (pH 8.0)
QS to 1000mL to 1Liter with ddH2O
Dilute 10X TAE 10:1 to make a 1X working solution
Permeabilization Buffer
1% v/v Triton X-100
1.9mM DTT
8mM EDTA
8mM Na2HPO4
24mM Tris-HCL
Z Buffer
900mL ddH2O
16.1g Na2HPO4 . 7H2O
5.5g NaH2PO4 . H2O
0.75g KCl
0.246g MgSO4 . 7H2O
pH to 7 and autoclave
Add 2.7uL/mL of b-mercaptoethanol (BME) when ready to use
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Appendix C: Primers and Plasmids
Arbitrary PCR primers
RdPa1: GGCCACGCGTCGACTAGTACNNNNNNNNNNAGAG
RdPa2: GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC
RdPa3: GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
R1TnM: TATAATGTGTGGAATTGTGAGCGG
Rd2Pa: GGCCACGCGTCGACTCTAGTAC
R2TnM: ACAGGAAACAGGACTCTAGAGG
TnMSq: CACCCAGCTTTCTTGTACAC
Gentamicin Screen primers
GentF: ATGTTACGCAGCAGCAACGATG
GentR: TTAGGTGGCGGTACTTGGGTC
PA3327 primers
PA3327EcoR1F: GCCGGAATTCGCCTTGTTTGACTCGCCCTGA
PA3327XbalR: GGCATCTAGACTGACCTTCCCAGGAGTCGA
PA3327 SOEF: GTTGAAGAGGACGCAGGGGTATGCTGGTCGCAGACATCCCCTGA
PA3327 SOER: TCAGGGGATGTCTGCGACCAGCATACCCCTGCGTCCTCTTCAAC
PA3327intF: CGGCATATCGAAACCTTCCT
PA3327intR: TGTTCTGGTGGAGTTTCACC
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Appendix D: Supplementary Figures
Transposon mutants and corresponding genes
Table 4. Transposon mutants and corresponding genes
MUTANT
GENE IDENTIFIED
TnM1

PA3327

TnM2

algR

TnM3

fimS

TnM4

lacZ

TnM5

lacZ

Site of transposon insertion in P. aeruginosa genome

Figure 9. Genomic position of PA3327 and the position of transposon insertion in P.
aeruginosa. The transposon inserted close to the 5’ end of the gene. Intergenic region
between clpP2 and PA3327 indicate PA3327 is the start of an eight member gene cluster
that has the non-ribosomal peptide synthetase as a subunit.
Arbitrary PCR products were sent for sequencing at the ETSU Molecular Biology Core Facility.
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Figure 10. Eight member gene cluster containing the PA337 encoding the putative nonribosomal peptide synthetase, fabH2 encoding an FAD-monooxygenase, and acp3
encoding a protein that catalyze the orthophosphoric monoester to alcohol and
orthophosphate.

Gel electrophoresis of Gent gene amplicon

Figure 7. Gel electrophoresis of transposon mutants containing gentamicin gene. All
mutants had the gent gene present in their genome. E. coli containing the pBT20 plasmid
was used as a positive control for the gent gene. The size of the gent gene amplicon is
around 500bp.

50

VITA
KWASI ODURO YEBOAH

Education:

M.S. Biology, Biomedical Sciences Concentration, East Tennessee
State University, Johnson City, Tennessee, 2020
M.S. Biochemistry, University of Ghana, Ghana, 2017
B.S. Biochemistry, University of Cape Coast, Ghana, 2011

Professional Experience:

Graduate Assistant, East Tennessee State University, College of
Arts and Sciences (Department of Biology), 2019
Graduate Assistant, East Tennessee State University, College of
Public Health (Dept. of Health Sciences), 2020
Laboratory Analyst, G2 Medical Laboratory Services,
Accra, 2016-2018
Research Assistance, Malaria Capacity Development Consortium
(MCDC), KNUST, Ghana, 2011-2013

Research Experience:

M.S. Biology, Biomedical Science, ETSU, 2020
Title: Identification of Transcription Regulators of The
AlgZ/R Two-Components Regulatory System in
Pseudomonas aeruginosa
M.S. Biochemistry, University of Ghana, Ghana, 2017
Title: Indicators of Disease Progression in HIV Infection:
Estimating Viral Load Using CD4 Count.
B.S. Biochemistry, University of Cape Coast, Ghana, 2011
51

Title: Determination of Acetalaldehyde Concentration in
“Pito” a Locally Brewed Beer in Ghana

52

